Fonar Corp

FONAR Corp designs, manufactures, sells, and services MRI scanners, with a distinctive focus on its Upright® MRI system that can image patients in weight-bearing positions. Through its HMCA subsidiary, the company also manages and operates diagnostic imaging centers, mainly in Florida, creating a combined equipment-and-services model around MRI utilization.

8,0 %

+1,4 %

8.45

8.28

— Fonar Corp
	%
MRI equipment	15% Design, manufacture, and sale of Upright® and other MRI scanners.
Service and maintenance	8% Repair, maintenance, and remote monitoring for installed MRI systems.
Upgrades and software enhancements	2% Hardware and software upgrades that extend scanner capability and life.
Physician management and diagnostic services	75% Management, billing, and operating services for imaging centers under HMCA.

FONAR sells MRI equipment primarily to private diagnostic imaging centers and hospital outpatient imaging facilities...

Private diagnostic imaging centersprimary
Buy Upright® MRI scanners and service contracts to differentiate imaging offerings and attract referrals.
Hospital outpatient imaging facilitiessecondary
Purchase MRI equipment for outpatient diagnostic capacity and clinical workflow.
Managed imaging centers and professional corporationsprimary
Use HMCA for management, billing, collections, staffing, and office support.
Installed-base scanner ownerssecondary
Buy maintenance, repairs, and upgrades to keep scanners operational and competitive.
Physician referral influencersemerging
Neurosurgeons, orthopedists, radiologists, and general physicians influence adoption of Upright® MRI.

FONAR is headquartered in Melville, New York and operates primarily in the United States...

•Headquartered in Melville, New York
•Six HMCA imaging facilities are located in Florida
•Most revenue is generated in the United States
•Foreign revenue is small relative to total revenue
•U.S. reimbursement and regulation drive demand and pricing

FONAR’s strategy is to expand MRI utilization by improving and adding managed imaging facilities, increasing scan...

Expand HMCA imaging capacity and scan volumeshort-term

Higher utilization drives recurring diagnostic-services revenue and improves fixed-cost absorption.

Grow installed-base service revenuemedium-term

Service and maintenance provide recurring income and deepen customer retention.

Differentiate Upright® MRI in niche clinical use casesmedium-term

Unique weight-bearing imaging supports a premium positioning versus standard MRI systems.

FONAR faces demand pressure from reimbursement cuts, intense competition from larger MRI manufacturers, and dependence...

critical

Cybersecurity and IT control weakness

Breaches or ransomware could disrupt operations, billing, and compliance; management disclosed a material weakness.

Scope: Imaging centers, billing systems, and internal controls
Materiality: high

high

MRI reimbursement pressure

Lower reimbursement can reduce customer willingness to buy scanners and pressure pricing.

Scope: Medical equipment sales and service base growth
Materiality: high

high

Competition from larger MRI manufacturers

GE, Siemens, Hitachi, and Philips have greater resources and scale.

Scope: Scanner sales and market share
Materiality: high

high

Third-party payer collection risk

HMCA and related PCs depend on collections from insurers, government programs, and patients.

Scope: Receivables and cash conversion
Materiality: high

Percentage-of-completion revenue recognition

Can shift revenue and margin recognition between periods

Receivable allowances and CECL

Affects reported revenue realizability and bad-debt expense

Contractual allowances and discounts

Impacts net revenue and balance-sheet receivables

Deferred tax asset valuation allowance

Can materially affect tax expense and net income

Non-controlling interests in HMCA/HDM

Changes net income attributable to FONAR shareholders

Fonar Corp

Cybersecurity and IT control weakness

MRI reimbursement pressure

Competition from larger MRI manufacturers

Third-party payer collection risk

LENSAR, Inc.

Hyperfine, Inc.

IRADIMED CORP

Sanara MedTech Inc.

Profound Medical Corp.

VYCOR MEDICAL INC